Arthritis Relief Plus Ltd is an Australian unlisted Public biotechnology company dedicated to enabling osteoarthritis sufferers achieve ‘Freedom to Move’. ARP’s patented platform technology has been substantiated by gold standard research published in medical journals by both Australian and US research institutions to verify the efficacy of the treatment of OA. Indeed, this treatment provides a new frontier in the effective management of OA pain and stiffness.